Dr. Amy Ayres McClung, MD

Dr. McClung practices at U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas.

Dr. McClung's NPI, 1033372586, was assigned on July 4, 2008. Dr. McClung graduated from UTMB Health in 2005. Dr. McClung holds Texas license N0960.

Dr. McClung's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza, at 1367 Dominion Plz, Tyler, TX 75703. The practice phone is (903) 534-6200.

Dr. McClung's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Dr. McClung to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McClung practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. McClung's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. McClung is board certified in dermatology by the American Board of Dermatology. Dr. McClung is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. McClung treats.

CMS data shows 6,748 Medicare services from Dr. McClung across 26 procedure codes in 2024, for 1,028 Medicare patients. Medicare paid $340,736 for them. Every service was in an office.

CMS counts 1,028 Medicare patients who saw Dr. McClung in 2024. The largest group is 65 to 74, with 533 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McClung's median patient age at 62, with 58% women.

In 2024, Dr. McClung wrote 2,376 Medicare Part D claims for 776 patients. 88% of them were for generic drugs. CMS names the drug for 2,102 of them, across 28 drugs with 11 or more claims each, at $846,525 in total drug cost. In 2023, CMS named 1,835 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McClung for performance year 2024, reported individually. Dr. McClung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 676 procedures of skin biopsy by Dr. McClung, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. McClung in 2011. Dr. McClung's most frequent co-authors are Eric Lee-An Cherng, MD, Yve Thaller Huttenbach, MD and Moise L. Levy, MD.

CMS Open Payments shows 1,300 general payments to Dr. McClung from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $3,397.

Dmand AI lists 1 award for Dr. McClung.

Dr. McClung graduated from UTMB Health in 2005. Dr. McClung is a member of AAD.

Dr. McClung is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.